Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Vilin Bio Med Merger & Restructuring

Vilin Bio Med received a 'No Objection' observation letter from the NSE regarding its merger with Chemgenix Laboratories. The scheme remains subject to further statutory and creditor approvals.

Source

NSE filing, NSE: VILINBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vilin Bio Med Ltd: key numbers

Share price
₹50.45
Market cap
₹76.94 Cr
Revenue (annual)
₹42.26 Cr
Net profit (annual)
₹1.93 Cr
P/E (TTM)
39.9×Sector 48.7×
Promoter holding
56.65%+0.00% QoQ
FII holding
0.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vilin Bio Med Ltd

All →

Other merger & restructuring announcements

All →